Medicines For Europe Urges Inclusion Of Essential Medicines In Industrial Policy Plans

Current IPCEI Proposals Do Not Address APIs Or Off-Patent Medicines

 
• By Chloe Kent

Medicines for Europe has called for the EU’s IPCEI on health to encourage access to manufacturing incentives for APIs and off-patent medicines, which so far have been left out of the initiative.

Flag of the European Union with the EU-member countries highlighted in yellow
The new IPCEI on Health has been unveiled by the French Presidency of the EU • Source: Alamy

More from Policy & Regulation

More from Generics Bulletin